Terminated PHASE4 INTERVENTIONAL 4-arm NCT01078987

Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) (NFD)

Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology

Sponsor: Loma Linda University

Conditions Nephrogenic Fibrosing Dermopathy Nephrogenic Systemic Fibrosis

Interventions Plasmapheresis

Updated 5 times since 2017 Last updated: Nov 19, 2014 Started: Feb 28, 2002 Primary completion: Mar 31, 2012 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient recruitment

Other terminated trials from Loma Linda University

See all terminations from Loma Linda University

A PHASE4 clinical study on Nephrogenic Fibrosing Dermopathy and Nephrogenic Systemic Fibrosis, this trial is terminated or withdrawn. The trial is conducted by Loma Linda University and has accumulated 5 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Feb 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Loma Linda University

Data source: Loma Linda University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Loma Linda, United States